Quick Takeaways
- MILLENNIUM MANAGEMENT LLC filed SCHEDULE 13G/A for ARS Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (SPRY).
- Disclosed ownership: 6%.
- Date of event: 27 Mar 2026.
MILLENNIUM MANAGEMENT LLC - 27 Mar 2026 SCHEDULE 13G/A Report for ARS Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (SPRY)
- Filing Manager
- MILLENNIUM MANAGEMENT LLC
- Reporting Manager
- Millennium Management LLC
- Symbol
- SPRY
- Shares outstanding
- 98,600,500 shares
- Disclosed Ownership
- 5,916,030 shares
- Ownership
- 6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 31 Mar 2026, 18:43:27 UTC
- Date of event
- 27 Mar 2026
- Previous filing
- 24 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"MILLENNIUM MANAGEMENT LLC disclosed 6% ownership in ARS Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (SPRY) on 27 Mar 2026."
What Changed
- Previous schedule filing date: 24 Mar 2026.
- Current filing was accepted on 31 Mar 2026, 18:43.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Integrated Core Strategies (US) LLC | 5.2% | 5,194,497 | 0 | 5,194,497 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Management LLC | 6% | 5,916,030 | 0 | 5,916,030 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Group Management LLC | 6% | 5,916,030 | 0 | 5,916,030 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Israel A. Englander | 6% | 5,916,030 | 0 | 5,916,030 | /s/ Israel A. Englander | Israel A. Englander |